Bronchodilators known as beta-2 agonists are extensively used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). Although beta-2 agonists have been linked to a lower incidence of Parkinson's disease in earlier research, this link was not detected in a recent registe
Washington [US], January 4 (ANI): The experts at the University of South Florida teamed up to advance potential asthma and COPD (chronic obstructive pulmonary disease) treatment that works differently than existing bronchodilators.
Washington D.C. [USA], Aug 17 (ANI): Researchers suggest that children with mild asthma can effectively manage the condition by using their two inhalers, one steroid, and the other bronchodilator when symptoms occur.